CTF1

Chr 16

cardiotrophin 1

Also known as: CT-1, CT1

The protein encoded by this gene is a secreted cytokine that induces cardiac myocyte hypertrophy in vitro. It has been shown to bind and activate the ILST/gp130 receoptor. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]

GeneReviewsResearchGenerating clinical summary…
MultiplemechanismLOEUF 1.74
Clinical SummaryCTF1
🧬
Gene-Disease Validity (ClinGen)
dilated cardiomyopathy · ADLimited

Limited evidence — not for standalone diagnostic reporting

Population Constraint (gnomAD)
Low constraint (pLI 0.04) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
140 VUS of 232 total submissions
📖
GeneReview available — CTF1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.74LOEUF
pLI 0.042
Z-score 0.51
OE 0.68 (0.271.74)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.81Z-score
OE missense 0.66 (0.490.90)
29 obs / 44.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.68 (0.271.74)
00.351.4
Missense OE?0.66 (0.490.90)
00.61.4
Synonymous OE?0.94
01.21.6
LoF obs/exp: 2 / 2.9Missense obs/exp: 29 / 44.2Syn Z: 0.22
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedCTF1-related dilated cardiomyopathyOTHERAD

This gene — mechanism propensity

DN
0.6162th %ile
GOF
0.75top 25%
LOF
0.3648th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

232 submitted variants in ClinVar

Classification Summary

VUS140
Likely Benign77
Benign3
Conflicting10
140
VUS
77
Likely Benign
3
Benign
10
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
0
0
0
Likely Pathogenic
0
0
0
0
0
VUS
12
123
4
1
140
Likely Benign
0
3
15
59
77
Benign
0
0
2
1
3
Conflicting
10
Total121262161230

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

12 pathogenic / likely-pathogenic (of 20) ClinVar copy-number / structural variants overlap CTF1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

CTF1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →